For instance, Silibinin, a polyphenolic compound from milk thistle, impedes glycolytic metabolism by inhibiting HIF-1α/LDH-A, reducing PD-L1 expression on cancer cells, and enhancing immune response via the glycolytic pathway. Here, HIF1A is linked to cancer.